Back
Editas Medicine Stock Price Chart
Sponsored
EDIT
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
EDIT
Editas Medicine
Last Price:
$1.20
Seasonality Move:
-11.28%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.36 | Sell |
20-day SMA: | 1.8 | Sell |
50-day SMA: | 2.52 | Sell |
200-day SMA: | 4.5 | Sell |
8-day EMA: | 1.41 | Sell |
20-day EMA: | 1.76 | Sell |
50-day EMA: | 2.37 | Sell |
200-day EMA: | 4.37 | Sell |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 22.26 | Sell |
Chaikin Money Flow: | -1048354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.5 - 2.34) | Sell |
Bollinger Bands (100): | (2.3 - 3.96) | Sell |
Editas Medicine Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.21 while EDIT 8-day simple moving average is 1.36, which is a Sell signal.
-
The stock price of EDIT is 1.21 while Editas Medicine 20-day SMA is 1.80, which makes it a Sell.
-
Editas Medicine 50-day simple moving average is 2.52 while EDIT share price is 1.21, making it a Sell technically.
-
EDIT stock price is 1.21 and Editas Medicine 200-day simple moving average is 4.50, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
11
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $1.21. The Score for EDIT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
99.9M
Price in USD:
1.21
Share Volume:
1.6M
Editas Medicine 52-Week Range
52-Week High:
11.58
52-Week Low:
1.20
Sell
11
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 1.21 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.21 while EDIT 8-day exponential moving average is 1.41, which is a Sell signal.
-
The stock price of EDIT is 1.21 while Editas Medicine 20-day EMA is 1.76, which makes it a Sell.
-
Editas Medicine 50-day exponential moving average is 2.37 while EDIT share price is 1.21, making it a Sell technically.
-
EDIT stock price is 1.21 and Editas Medicine 200-day simple moving average is 4.37, creating a Sell signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting Editas Medicine is a Sell
-
Editas Medicine Relative Strength Index (RSI) is 22.26, which suggest Editas Medicine is oversold
-
The Bollinger Bands (25) for Editas Medicine is (1.5 - 2.34), which suggest Editas Medicine is a Sell
-
The Bollinger Bands (100) for Editas Medicine is (2.3 - 3.96), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.